How to use C-reactive protein in acute coronary care

Luigi M. Biasucci; Wolfgang Koenig; Johannes Mair; Christian Mueller; Mario Plebani; Bertil Lindahl; Nader Rifai; Per Venge; Christian Hamm; Evangelos Giannitsis; Kurt Huber; Marcello Galvani; Marco Tubaro; Paul Collinson; Joseph S. Alpert; Yonathan Hasin; Hugo Katus; Allan S. Jaffe; Kristian Thygesen

doi:10.1093/eurheartj/eht435

How to use C-reactive protein in acute coronary care

Luigi M. Biasucci, Wolfgang Koenig, Johannes Mair, Christian Mueller, Mario Plebani, Bertil Lindahl, Nader Rifai, Per Venge, Christian Hamm, Evangelos Giannitsis, Kurt Huber, Marcello Galvani, Marco Tubaro, Paul Collinson, Joseph S. Alpert, Yonathan Hasin, Hugo Katus, Allan S. Jaffe, Kristian Thygesen

Aarhus University

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Original language	English
Pages (from-to)	3687-3690
Number of pages	4
Journal	European Heart Journal
Volume	34
Issue number	48
DOIs	https://doi.org/10.1093/eurheartj/eht435
State	Published - 21 Dec 2013
Externally published	Yes

Bibliographical note

Funding Information:
Conflict of interest: LB has been consultant for Siemens Diagnostics, Roche Diagnostics and Abbott Diagnostics; WK has received lecture honoraria from AstraZeneca, Roche and Novartis and is a member of the Executive Steering Committee of CANTOS; JM has received fees from Philipps Health Care Incubator; EG received lecture honoraria from Roche Diagnostics, Bayer Vital, Mitsubishi Chemicals and was consultant for Roche Diagnostics; CM received lecture honoraria from Abbott Diagnostics, Biosite, Brahms, Roche Diagnostics, Siemens Diagnostics and he has received support from the Swiss National Science Foundation (PP00B-102853), the Swiss Heart Foundation, Abbott Diagnostics, Biosite, Brahms, Nano-sphere, Roche Diagnostics and Siemens Diagnostics; BL has received research grants from Roche Diagnostics and Radiometer A/S, lecture fees from Roche Diagnostics and Siemens Healthcare Diagnostics and has been member of the scientific advisory boards of Philips Healthcare, Siemens Healthcare, Beckman Coulter, FIOMI and bio-Merieux; HK holds a patent on the cardiac troponin T assay jointly with Roche Diagnostics; ASJ has received consulting honoraria from most of the major diagnostic companies including Beckman-Coulter and Siemens; MT has been member of the advisory boards of Roche Diagnostics and Abbott Diagnostics and he has received lecture honoraria from Biosite/Inverness, Abbott Diagnostics and Dade Behring; JA received lecture honoraria from Roche Diagnostics and Siemens Diagnostics; PC is member of the Diagnostics Advisory Committee of the National Institute of Clinical Excellence in the UK; CH has been consultant for Abbott Diagnostics and Roche Diagnostics; MG has been consultant for Roche Diagnostics and he has received research grants from Roche Diagnostics, Siemens Diagnostics and Beckman Coulter; MP received consulting honoraria from Siemens, Roche and Abbott Diagnostics; PV has received lecture honoraria and research grants from Abbott, Beckman Coulter, Roche Diagnostics, Siemens and is currently consultant for Abbott, bioMerieux, Philips and Radiometer.

Funding

Conflict of interest: LB has been consultant for Siemens Diagnostics, Roche Diagnostics and Abbott Diagnostics; WK has received lecture honoraria from AstraZeneca, Roche and Novartis and is a member of the Executive Steering Committee of CANTOS; JM has received fees from Philipps Health Care Incubator; EG received lecture honoraria from Roche Diagnostics, Bayer Vital, Mitsubishi Chemicals and was consultant for Roche Diagnostics; CM received lecture honoraria from Abbott Diagnostics, Biosite, Brahms, Roche Diagnostics, Siemens Diagnostics and he has received support from the Swiss National Science Foundation (PP00B-102853), the Swiss Heart Foundation, Abbott Diagnostics, Biosite, Brahms, Nano-sphere, Roche Diagnostics and Siemens Diagnostics; BL has received research grants from Roche Diagnostics and Radiometer A/S, lecture fees from Roche Diagnostics and Siemens Healthcare Diagnostics and has been member of the scientific advisory boards of Philips Healthcare, Siemens Healthcare, Beckman Coulter, FIOMI and bio-Merieux; HK holds a patent on the cardiac troponin T assay jointly with Roche Diagnostics; ASJ has received consulting honoraria from most of the major diagnostic companies including Beckman-Coulter and Siemens; MT has been member of the advisory boards of Roche Diagnostics and Abbott Diagnostics and he has received lecture honoraria from Biosite/Inverness, Abbott Diagnostics and Dade Behring; JA received lecture honoraria from Roche Diagnostics and Siemens Diagnostics; PC is member of the Diagnostics Advisory Committee of the National Institute of Clinical Excellence in the UK; CH has been consultant for Abbott Diagnostics and Roche Diagnostics; MG has been consultant for Roche Diagnostics and he has received research grants from Roche Diagnostics, Siemens Diagnostics and Beckman Coulter; MP received consulting honoraria from Siemens, Roche and Abbott Diagnostics; PV has received lecture honoraria and research grants from Abbott, Beckman Coulter, Roche Diagnostics, Siemens and is currently consultant for Abbott, bioMerieux, Philips and Radiometer.

Funders	Funder number
Beckman-Coulter and Siemens
Mitsubishi Chemicals
National Institute of Clinical Excellence
Abbott Fund
Beckman Coulter Foundation
Roche
Bayer Vital
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung	PP00B-102853
Schweizerische Herzstiftung

Access to Document

10.1093/eurheartj/eht435

Cite this

Biasucci, L. M., Koenig, W., Mair, J., Mueller, C., Plebani, M., Lindahl, B., Rifai, N., Venge, P., Hamm, C., Giannitsis, E., Huber, K., Galvani, M., Tubaro, M., Collinson, P., Alpert, J. S., Hasin, Y., Katus, H., Jaffe, A. S., & Thygesen, K. (2013). How to use C-reactive protein in acute coronary care. European Heart Journal, 34(48), 3687-3690. https://doi.org/10.1093/eurheartj/eht435

@article{f15f0dad0d7740f8ae95e1f39cd103bc,

title = "How to use C-reactive protein in acute coronary care",

author = "Biasucci, {Luigi M.} and Wolfgang Koenig and Johannes Mair and Christian Mueller and Mario Plebani and Bertil Lindahl and Nader Rifai and Per Venge and Christian Hamm and Evangelos Giannitsis and Kurt Huber and Marcello Galvani and Marco Tubaro and Paul Collinson and Alpert, {Joseph S.} and Yonathan Hasin and Hugo Katus and Jaffe, {Allan S.} and Kristian Thygesen",

note = "Funding Information: Conflict of interest: LB has been consultant for Siemens Diagnostics, Roche Diagnostics and Abbott Diagnostics; WK has received lecture honoraria from AstraZeneca, Roche and Novartis and is a member of the Executive Steering Committee of CANTOS; JM has received fees from Philipps Health Care Incubator; EG received lecture honoraria from Roche Diagnostics, Bayer Vital, Mitsubishi Chemicals and was consultant for Roche Diagnostics; CM received lecture honoraria from Abbott Diagnostics, Biosite, Brahms, Roche Diagnostics, Siemens Diagnostics and he has received support from the Swiss National Science Foundation (PP00B-102853), the Swiss Heart Foundation, Abbott Diagnostics, Biosite, Brahms, Nano-sphere, Roche Diagnostics and Siemens Diagnostics; BL has received research grants from Roche Diagnostics and Radiometer A/S, lecture fees from Roche Diagnostics and Siemens Healthcare Diagnostics and has been member of the scientific advisory boards of Philips Healthcare, Siemens Healthcare, Beckman Coulter, FIOMI and bio-Merieux; HK holds a patent on the cardiac troponin T assay jointly with Roche Diagnostics; ASJ has received consulting honoraria from most of the major diagnostic companies including Beckman-Coulter and Siemens; MT has been member of the advisory boards of Roche Diagnostics and Abbott Diagnostics and he has received lecture honoraria from Biosite/Inverness, Abbott Diagnostics and Dade Behring; JA received lecture honoraria from Roche Diagnostics and Siemens Diagnostics; PC is member of the Diagnostics Advisory Committee of the National Institute of Clinical Excellence in the UK; CH has been consultant for Abbott Diagnostics and Roche Diagnostics; MG has been consultant for Roche Diagnostics and he has received research grants from Roche Diagnostics, Siemens Diagnostics and Beckman Coulter; MP received consulting honoraria from Siemens, Roche and Abbott Diagnostics; PV has received lecture honoraria and research grants from Abbott, Beckman Coulter, Roche Diagnostics, Siemens and is currently consultant for Abbott, bioMerieux, Philips and Radiometer.",

year = "2013",

month = dec,

day = "21",

doi = "10.1093/eurheartj/eht435",

language = "אנגלית",

volume = "34",

pages = "3687--3690",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "48",

}

Biasucci, LM, Koenig, W, Mair, J, Mueller, C, Plebani, M, Lindahl, B, Rifai, N, Venge, P, Hamm, C, Giannitsis, E, Huber, K, Galvani, M, Tubaro, M, Collinson, P, Alpert, JS, Hasin, Y, Katus, H, Jaffe, AS & Thygesen, K 2013, 'How to use C-reactive protein in acute coronary care', European Heart Journal, vol. 34, no. 48, pp. 3687-3690. https://doi.org/10.1093/eurheartj/eht435

TY - JOUR

T1 - How to use C-reactive protein in acute coronary care

AU - Biasucci, Luigi M.

AU - Koenig, Wolfgang

AU - Mair, Johannes

AU - Mueller, Christian

AU - Plebani, Mario

AU - Lindahl, Bertil

AU - Rifai, Nader

AU - Venge, Per

AU - Hamm, Christian

AU - Giannitsis, Evangelos

AU - Huber, Kurt

AU - Galvani, Marcello

AU - Tubaro, Marco

AU - Collinson, Paul

AU - Alpert, Joseph S.

AU - Hasin, Yonathan

AU - Katus, Hugo

AU - Jaffe, Allan S.

AU - Thygesen, Kristian

N1 - Funding Information: Conflict of interest: LB has been consultant for Siemens Diagnostics, Roche Diagnostics and Abbott Diagnostics; WK has received lecture honoraria from AstraZeneca, Roche and Novartis and is a member of the Executive Steering Committee of CANTOS; JM has received fees from Philipps Health Care Incubator; EG received lecture honoraria from Roche Diagnostics, Bayer Vital, Mitsubishi Chemicals and was consultant for Roche Diagnostics; CM received lecture honoraria from Abbott Diagnostics, Biosite, Brahms, Roche Diagnostics, Siemens Diagnostics and he has received support from the Swiss National Science Foundation (PP00B-102853), the Swiss Heart Foundation, Abbott Diagnostics, Biosite, Brahms, Nano-sphere, Roche Diagnostics and Siemens Diagnostics; BL has received research grants from Roche Diagnostics and Radiometer A/S, lecture fees from Roche Diagnostics and Siemens Healthcare Diagnostics and has been member of the scientific advisory boards of Philips Healthcare, Siemens Healthcare, Beckman Coulter, FIOMI and bio-Merieux; HK holds a patent on the cardiac troponin T assay jointly with Roche Diagnostics; ASJ has received consulting honoraria from most of the major diagnostic companies including Beckman-Coulter and Siemens; MT has been member of the advisory boards of Roche Diagnostics and Abbott Diagnostics and he has received lecture honoraria from Biosite/Inverness, Abbott Diagnostics and Dade Behring; JA received lecture honoraria from Roche Diagnostics and Siemens Diagnostics; PC is member of the Diagnostics Advisory Committee of the National Institute of Clinical Excellence in the UK; CH has been consultant for Abbott Diagnostics and Roche Diagnostics; MG has been consultant for Roche Diagnostics and he has received research grants from Roche Diagnostics, Siemens Diagnostics and Beckman Coulter; MP received consulting honoraria from Siemens, Roche and Abbott Diagnostics; PV has received lecture honoraria and research grants from Abbott, Beckman Coulter, Roche Diagnostics, Siemens and is currently consultant for Abbott, bioMerieux, Philips and Radiometer.

PY - 2013/12/21

Y1 - 2013/12/21

UR - http://www.scopus.com/inward/record.url?scp=84891504218&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/eht435

DO - 10.1093/eurheartj/eht435

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 24204013

AN - SCOPUS:84891504218

SN - 0195-668X

VL - 34

SP - 3687

EP - 3690

JO - European Heart Journal

JF - European Heart Journal

IS - 48

ER -

How to use C-reactive protein in acute coronary care

Bibliographical note

Funding

Access to Document

Other files and links

Cite this